Economic Evaluation of Three Two-Drug Chemotherapy Regimens in Advanced Non-Small-Cell Lung Cancer

By Neymark Niels  

PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. : 1155-1166

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?

By Giovannetti Elisa   Toffalorio Francesca   De Pas Tommaso   Peters Godefridus J  

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1073-1086

Future Medicine

Access to resources Recommend Favorite

Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

By Schuette W.  

Clinical Drug Investigation, Vol. 21, Iss. 3, 2001-03 ,pp. : 161-168

Adis International

Access to resources Recommend Favorite

Axitinib for the treatment of advanced non-small-cell lung cancer

By King Judy W  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 765-773

Informa Healthcare

Access to resources Recommend Favorite

Afatinib for the treatment of advanced non-small-cell lung cancer

By Genova Carlo   Rijavec Erika   Barletta Giulia   Burrafato Giovanni   Biello Federica   Dal Bello Maria Giovanna   Coco Simona   Truini Anna   Alama Angela   Boccardo Francesco   Grossi Francesco  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 889-903

Informa Healthcare

Access to resources Recommend Favorite